202 related articles for article (PubMed ID: 21803853)
1. Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation.
Zhang G; Xiang B; Dong A; Skoda RC; Daugherty A; Smyth SS; Du X; Li Z
Blood; 2011 Sep; 118(13):3670-9. PubMed ID: 21803853
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase.
Rukoyatkina N; Walter U; Friebe A; Gambaryan S
Thromb Haemost; 2011 Nov; 106(5):922-33. PubMed ID: 21800013
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition.
Dangel O; Mergia E; Karlisch K; Groneberg D; Koesling D; Friebe A
J Thromb Haemost; 2010 Jun; 8(6):1343-52. PubMed ID: 20149081
[TBL] [Abstract][Full Text] [Related]
4. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway.
Mendes-Silverio CB; Leiria LO; Morganti RP; Anhê GF; Marcondes S; Mónica FZ; De Nucci G; Antunes E
PLoS One; 2012; 7(11):e47223. PubMed ID: 23144808
[TBL] [Abstract][Full Text] [Related]
5. Stimulatory roles of nitric-oxide synthase 3 and guanylyl cyclase in platelet activation.
Marjanovic JA; Li Z; Stojanovic A; Du X
J Biol Chem; 2005 Nov; 280(45):37430-8. PubMed ID: 16144836
[TBL] [Abstract][Full Text] [Related]
6. Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
Erdmann J; Stark K; Esslinger UB; Rumpf PM; Koesling D; de Wit C; Kaiser FJ; Braunholz D; Medack A; Fischer M; Zimmermann ME; Tennstedt S; Graf E; Eck S; Aherrahrou Z; Nahrstaedt J; Willenborg C; Bruse P; Brænne I; Nöthen MM; Hofmann P; Braund PS; Mergia E; Reinhard W; Burgdorf C; Schreiber S; Balmforth AJ; Hall AS; Bertram L; Steinhagen-Thiessen E; Li SC; März W; Reilly M; Kathiresan S; McPherson R; Walter U; ; Ott J; Samani NJ; Strom TM; Meitinger T; Hengstenberg C; Schunkert H
Nature; 2013 Dec; 504(7480):432-6. PubMed ID: 24213632
[TBL] [Abstract][Full Text] [Related]
7. Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide.
Zheng X; Ying L; Liu J; Dou D; He Q; Leung SW; Man RY; Vanhoutte PM; Gao Y
Cardiovasc Res; 2011 Jun; 90(3):565-72. PubMed ID: 21248051
[TBL] [Abstract][Full Text] [Related]
8. The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood.
Reiss C; Mindukshev I; Bischoff V; Subramanian H; Kehrer L; Friebe A; Stasch JP; Gambaryan S; Walter U
Br J Pharmacol; 2015 Nov; 172(21):5199-210. PubMed ID: 26282717
[TBL] [Abstract][Full Text] [Related]
9. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
[TBL] [Abstract][Full Text] [Related]
10. Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.
Hervé D; Philippi A; Belbouab R; Zerah M; Chabrier S; Collardeau-Frachon S; Bergametti F; Essongue A; Berrou E; Krivosic V; Sainte-Rose C; Houdart E; Adam F; Billiemaz K; Lebret M; Roman S; Passemard S; Boulday G; Delaforge A; Guey S; Dray X; Chabriat H; Brouckaert P; Bryckaert M; Tournier-Lasserve E
Am J Hum Genet; 2014 Mar; 94(3):385-94. PubMed ID: 24581742
[TBL] [Abstract][Full Text] [Related]
11. Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats.
Schäfer A; Flierl U; Kobsar A; Eigenthaler M; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2813-8. PubMed ID: 17023677
[TBL] [Abstract][Full Text] [Related]
12. Molecular variants of soluble guanylyl cyclase affecting cardiovascular risk.
Wobst J; Rumpf PM; Dang TA; Segura-Puimedon M; Erdmann J; Schunkert H
Circ J; 2015; 79(3):463-9. PubMed ID: 25746521
[TBL] [Abstract][Full Text] [Related]
13. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
[TBL] [Abstract][Full Text] [Related]
14. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y
Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655
[TBL] [Abstract][Full Text] [Related]
15. Guanylyl cyclase activator ataciguat improves vascular function and reduces platelet activation in heart failure.
Schäfer A; Fraccarollo D; Werner L; Bauersachs J
Pharmacol Res; 2010 Nov; 62(5):432-8. PubMed ID: 20600916
[TBL] [Abstract][Full Text] [Related]
16. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
17. Analysis of nitric oxide-sensitive guanylyl cyclase in human platelets before and after aggregation.
Kempfert J; Behrends S
Platelets; 2003; 14(7-8):429-35. PubMed ID: 14713512
[TBL] [Abstract][Full Text] [Related]
18. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
Mujoo K; Sharin VG; Martin E; Choi BK; Sloan C; Nikonoff LE; Kots AY; Murad F
Nitric Oxide; 2010 Jan; 22(1):43-50. PubMed ID: 19948239
[TBL] [Abstract][Full Text] [Related]
19. sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling.
Cawley SM; Kolodziej S; Ichinose F; Brouckaert P; Buys ES; Bloch KD
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H157-63. PubMed ID: 21536853
[TBL] [Abstract][Full Text] [Related]
20. Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.
Vanneste G; Dhaese I; Sips P; Buys E; Brouckaert P; Lefebvre RA
J Physiol; 2007 Nov; 584(Pt 3):907-20. PubMed ID: 17717014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
